Latest news
SKYSCRAPER-03 Trial: Critical Setback for TIGIT Consolidation in Stage III NSCLC - oncodaily.comoncodaily.com · Sat, 08 Aug 2026 11:36:12 GMTLCT Gains Ground in EGFR-Mutated NSCLC - OncLiveOncLive · Fri, 07 Aug 2026 14:05:45 GMTPhase 2 Study Evaluates BIO 300 With SBRT in Early-Stage NSCLC and ILD - oncodaily.comoncodaily.com · Sun, 02 Aug 2026 15:27:55 GMTTargeted Therapy Expands Into Adjuvant and Neoadjuvant Settings for Oncogene-Driven Early-Stage NSCLC - OncLiveOncLive · Wed, 29 Jul 2026 16:01:06 GMTLong-Term Data Refine the Role of Immunotherapy Across Early-Stage NSCLC Settings - OncLiveOncLive · Tue, 28 Jul 2026 07:00:00 GMTProton Pump Inhibitor, Antibiotic Exposure Linked to Worse Durvalumab Outcomes in Unresectable Stage III NSCLC - The ASCO PostThe ASCO Post · Mon, 27 Jul 2026 14:59:46 GMT